Results of a patient survey exploring skin symptoms in a menopause clinic

BackgroundThe menopause leads to a reduction in circulating estrogen and progesterone levels, which trigger physiological changes in women. This includes cutaneous changes where these hormonal receptors are present and potential deterioration of previously diagnosed dermatoses. We suspect that the prevalence of skin, hair, vulval and oral symptoms experienced during the menopausal time may be underestimated and may not be considered associated with the menopause in presenting patients.MethodsA survey was conducted to investigate the dermatological symptoms experienced by women attending a menopause clinic. The Dermatology Life Quality Index (DLQI) was also recorded for each patient.ResultsA high prevalence of skin, hair, vulval and oral symptoms was reported by participants, and these symptoms appear to have an impact on quality of life.ConclusionThese findings highlight the need for research into the management of these symptoms, including the role of hormone replacement therapy amongst other treatment modalities.